Instil Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Instil Bio
TIL Stock  USD 24.76  1.40  5.99%   
Instil Bio financial statements provide useful quarterly and yearly information to potential Instil Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Instil Bio financial statements helps investors assess Instil Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Instil Bio's valuation are summarized below:
Gross Profit
138 K
Market Capitalization
152.4 M
Enterprise Value Revenue
43.2 K
Earnings Share
(11.56)
There are over one hundred sixteen available fundamental trends for Instil Bio, which can be analyzed over time and compared to other ratios. We recommend to confirm Instil Bio's regular fundamental drivers against the all of the trends between 2010 and 2024. The value of Market Cap is estimated to slide to about 54.1 M. The Enterprise Value is projected to slide to about 136.5 M
Check Instil Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Instil Bio's main balance sheet or income statement drivers, such as Net Interest Income of 4.7 M, Interest Income of 8.9 M or Depreciation And Amortization of 3 M, as well as many indicators such as Price To Sales Ratio of 19.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.23. Instil financial statements analysis is a perfect complement when working with Instil Bio Valuation or Volatility modules.
  
Check out the analysis of Instil Bio Correlation against competitors.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

Instil Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets384.2 M325.6 M147.7 M
Slightly volatile
Other Current Liabilities7.2 M7.6 M6.1 M
Slightly volatile
Total Current Liabilities10 M10.6 M8.1 M
Slightly volatile
Property Plant And Equipment Net116.1 M141.1 M43.1 M
Slightly volatile
Accounts Payable2.2 M1.2 M1.6 M
Slightly volatile
Cash10.2 M10.7 M28.9 M
Pretty Stable
Non Current Assets Total131.3 M164.9 M48.6 M
Slightly volatile
Cash And Short Term Investments245.5 M150.4 M96.1 M
Slightly volatile
Common Stock Shares Outstanding7.1 M6.5 M6.5 M
Slightly volatile
Liabilities And Stockholders Equity384.2 M325.6 M147.7 M
Slightly volatile
Non Current Liabilities Total87.8 M89.2 M51.4 M
Slightly volatile
Other Current Assets8.8 M10.4 M3.3 M
Slightly volatile
Total Liabilities103.7 M99.8 M59.9 M
Slightly volatile
Property Plant And Equipment Gross119.7 M148.6 M44.4 M
Slightly volatile
Total Current Assets252.9 M160.8 M99.1 M
Slightly volatile
Net Working Capital231 M150.2 M90.1 M
Slightly volatile
Property Plant Equipment147.3 M140.3 M39.3 M
Slightly volatile
Other Liabilities14.7 M15.4 M13.6 M
Slightly volatile
Non Currrent Assets Other607 K639 K2.1 M
Pretty Stable
Other Assets1 M1.1 M51.9 M
Pretty Stable
Net Receivables6.2 M9.4 M4.5 M
Slightly volatile
Inventory944.8 K1.1 M1.2 M
Slightly volatile
Deferred Long Term Liabilities1.3 M1.5 M1.6 M
Slightly volatile
Non Current Liabilities Other7 M4.9 M10.1 M
Slightly volatile
Intangible Assets8.1 M9.1 M9.9 M
Slightly volatile
Capital Surpluse605.6 M681.3 M741.9 M
Slightly volatile
Short and Long Term Debt Total91.3 M86.1 M81.1 M
Slightly volatile
Long Term Debt84.6 M81.4 M73.8 M
Slightly volatile
Short Term Debt1.7 M1.8 M2.3 M
Slightly volatile

Instil Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income4.7 M4.5 M1 M
Slightly volatile
Interest Income8.9 M8.5 M1.5 M
Slightly volatile
Depreciation And Amortization3 M4.8 M1.1 M
Slightly volatile
Selling General Administrative38.5 M47.6 M15.8 M
Slightly volatile
Other Operating Expenses107.7 M90.5 M43.8 M
Slightly volatile
Research Development69.2 M43 M28 M
Slightly volatile
Cost Of Revenue3.7 M4.8 M1.3 M
Slightly volatile
Total Operating Expenses106.7 M85.8 M43.4 M
Slightly volatile
Reconciled Depreciation3.3 M5.8 M1.2 M
Slightly volatile
Selling And Marketing Expenses3.8 M4.3 M4.7 M
Slightly volatile

Instil Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation16.9 M18.2 M6.4 M
Slightly volatile
Depreciation3 M4.8 M1.1 M
Slightly volatile
Other Non Cash Items62 M59 M9.9 M
Slightly volatile
Capital Expenditures19.6 M20.7 M16.1 M
Slightly volatile
Change To Operating Activities1.1 M573.9 K386.8 K
Slightly volatile
Total Cash From Financing Activities7.7 M8.1 M62.9 M
Slightly volatile
End Period Cash Flow10.2 M10.7 M28.9 M
Pretty Stable
Change To Netincome33.3 M31.7 M9 M
Slightly volatile
Sale Purchase Of Stock314.6 M353.9 M385.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio19.7 K22.1 K24.1 K
Slightly volatile
Days Sales Outstanding6.7 K7.6 K8.2 K
Slightly volatile
Stock Based Compensation To Revenue9.8911.1312.1153
Slightly volatile
Capex To Depreciation4.134.3446148
Slightly volatile
EV To Sales18.3 K20.5 K22.4 K
Slightly volatile
Payables Turnover4.123.92410.785
Slightly volatile
Sales General And Administrative To Revenue83.3893.8102
Slightly volatile
Research And Ddevelopement To Revenue112127138
Slightly volatile
Capex To Revenue295331361
Slightly volatile
Cash Per Share27.723.348614.2206
Slightly volatile
Days Payables Outstanding88.3693.015112 K
Slightly volatile
Income Quality0.810.52550.7881
Slightly volatile
Intangibles To Total Assets0.04160.02980.0446
Slightly volatile
Current Ratio9.5615.22488.5432
Slightly volatile
Receivables Turnover0.03480.03910.0426
Slightly volatile
Graham Number95.3713749.0565
Slightly volatile
Debt To Equity0.220.36060.2112
Slightly volatile
Capex Per Share5.323.1772.6424
Slightly volatile
Revenue Per Share0.01720.01940.0211
Slightly volatile
Interest Debt Per Share9.9113.320611.4837
Very volatile
Debt To Assets0.160.25010.1574
Slightly volatile
Days Of Payables Outstanding88.3693.015112 K
Slightly volatile
Ebt Per Ebit1.120.98061.0083
Slightly volatile
Long Term Debt To Capitalization0.180.2650.1735
Slightly volatile
Total Debt To Capitalization0.180.2650.1735
Slightly volatile
Debt Equity Ratio0.220.36060.2112
Slightly volatile
Quick Ratio9.5415.22488.5359
Slightly volatile
Net Income Per E B T1.11.141.0087
Slightly volatile
Cash Ratio0.961.0135.6704
Slightly volatile
Days Of Sales Outstanding6.7 K7.6 K8.2 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.771.25191.3411
Slightly volatile
Fixed Asset Turnover0.0020.00220.0024
Slightly volatile
Debt Ratio0.160.25010.1574
Slightly volatile
Price Sales Ratio19.7 K22.1 K24.1 K
Slightly volatile
Asset Turnover3.0E-44.0E-44.0E-4
Slightly volatile

Instil Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap54.1 M57 M2.6 B
Slightly volatile
Enterprise Value136.5 M143.7 M2.6 B
Slightly volatile

Instil Fundamental Market Drivers

Cash And Short Term Investments150.4 M

Instil Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Instil Bio Financial Statements

Instil Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Instil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue4.8 M3.7 M
Stock Based Compensation To Revenue 11.13  9.89 
Sales General And Administrative To Revenue 93.80  83.38 
Research And Ddevelopement To Revenue 126.52  112.46 
Capex To Revenue 331.41  294.58 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(219.42)(230.39)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:
How To Invest In Instil
Details
Is Instil Stock a good investment?
Details
What is Instil Bio's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Instil Bio Correlation against competitors.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.56)
Return On Assets
(0.12)
Return On Equity
(0.49)
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY